Determination of Posture in Patients With Restrictive and Obstructive Lung Disease
Launched by HACETTEPE UNIVERSITY · Mar 5, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how posture affects patients with different types of lung diseases, including Chronic Obstructive Pulmonary Disease (COPD), asthma, cystic fibrosis, bronchiectasis, and diffuse parenchymal lung diseases. Researchers want to find out how various factors related to posture may influence the breathing and overall health of these patients.
To participate in the trial, you need to be between 18 to 74 years old and have a stable lung condition. For example, if you have COPD, you should be over 55 years old and in stable health for at least the last month. There are certain conditions that may prevent you from joining, like recent spine surgery or receiving long-term oxygen therapy. If you do participate, you can expect to be involved in assessments that will help researchers better understand the relationship between posture and lung function. This study has not started recruiting participants yet, but it aims to gather valuable information that could improve care for people with lung diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Chronic Obstructive Pulmonary Disease Group Inclusion Criteria:
- • Over 55 years old,
- • Stage 1-2-3-4 according to the GOLD,
- • Being clinically stable for the last 4 weeks.
- Chronic Obstructive Pulmonary Disease Group Exclusion Criteria:
- • Receiving long-term oxygen therapy,
- • Having central and peripheral vestibular disease,
- • Communication problems, known mental and cognitive problems,
- • Having undergone any surgical intervention related to the spine within the last six months,
- Inclusion Criteria for the Cystic Fibrosis Group:
- • Being diagnosed with CF as a result of two sweat tests,
- • Being over 18 years old.
- Cystic Fibrosis Group Exclusion Criteria:
- • Being in acute pulmonary exacerbation period,
- • Receiving long-term oxygen therapy,
- • Having undergone any surgical intervention related to the spine within the last six months,
- Inclusion Criteria for the Asthma Group:
- • Diagnosed with asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA),
- • Clinically stable for the last 1 month
- • Being over 18 years old.
- Asthma Group Exclusion Criteria:
- • Change in medication for the last 1 month.
- • Having undergone any surgical intervention related to the spine in the last six months,
- Inclusion Criteria for Bronchiectasis Group:
- • Being over 18 years old,
- • Being diagnosed with bronchiectasis other than cystic fibrosis,
- • Being clinically stable for the last 1 month.
- Bronchiectasis Group Exclusion Criteria:
- • Receiving long-term oxygen therapy,
- • Having undergone any surgical intervention related to the spine in the last six months.
- Diffuse Parenchymal Lung Diseases Inclusion Criteria:
- • Being diagnosed with diffuse parenchymal lung according to American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,
- • Being over 18 years old,
- • Having volunteered to participate in the research,
- • To be clinically stable and to have comorbid conditions (such as hypertension, diabetes) under control,
- Diffuse Parenchymal Lung Diseases Exclusion Criteria:
- • Having undergone any surgical intervention related to the spine within the last six months,
- • Having exacerbation in the last 3 months
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Aynur Demirel
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported